Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Clinical trial NCT02626455 · TERMINATED

Trial details

NCT number: NCT02626455
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2016-01-06
Primary completion: 2023-09-15
Enrollment: 551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.